Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2017

Open Access 01-12-2017 | Research

Retrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at Mount Sinai Hospital, 2010 to 2015

Authors: Marko Oydanich, Tanis C. Dingle, Camille L. Hamula, Claudia Ghisa, Penny Asbell

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2017

Login to get access

Abstract

Background

Antimicrobial resistance has emerged as a major threat to global public health. Thus, the surveillance of changes in antimicrobial resistance in local and global settings is a paramount necessity. While many studies have tracked antimicrobial resistance, only a small percentage surveyed ocular isolates. The purpose of this study was to report the in vitro susceptibility of bacterial pathogens isolated from ocular samples in New York, NY from 2010 to 2015.

Methods

A retrospective review of ocular isolates was conducted. All organisms were collected by 25 separate inpatient wards and outpatient clinics, and were analyzed by the clinical microbiology laboratory at Mount Sinai Hospital. Clinical Laboratory and Standards Institute (CLSI) guidelines were followed for susceptibility testing and breakpoint interpretations.

Results

A total of 549 bacterial organisms were isolated from 1664 cultures (33%) during the 6-year study period. Of these, 358 isolates (65.2%) underwent susceptibility testing. 182 (50.8%) isolates were Gram-positive. The most common Gram-positive bacterium was Staphylococcus aureus (62.1%). Methicillin-resistance decreased in S. aureus isolates (31.3% in 2010, 14.1% in 2015) but was without significant change (p = 0.25). When analyzing all S. aureus isolates recovered during the study period, there were significantly more methicillin-resistant S. aureus (MRSA) isolates resistant to fluoroquinolones (p <0.0001), erythromycin (p <0.0001), and trimethoprim/sulfamethoxazole (TMP/SMZ; p <0.05). Overall, Streptococcus pneumoniae isolates showed reduced susceptibility to erythromycin, but were otherwise susceptible to the other antimicrobials tested. Haemophilus influenzae (26.1%) and Pseudomonas aeruginosa (23.9%) were the most common Gram-negative bacteria isolated. Resistance to ampicillin and TMP/SMZ was observed in several of the H. influenzae isolates. P. aeruginosa isolates did not show high resistance overall, however, it was noted that isolates resistant to meropenem were also resistant to other antimicrobials (p < 0.01).

Conclusion

Overall, antimicrobial resistance was infrequent for the Gram-negative and Gram-positive bacteria analyzed. While the MRSA isolates demonstrated increased resistance to multiple antimicrobial classes, this is expected for this pathogen. Due to the continued use of broad-spectrum oral and systemic antimicrobials to treat ocular infections, findings of this study and other surveillance studies specific to ocular isolates should be used as resources in effective decision making in the treatment of ocular disease.
Literature
1.
go back to reference Sand D, et al. Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience. Ophthalmology. 2015;122(5):918–24.CrossRefPubMed Sand D, et al. Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience. Ophthalmology. 2015;122(5):918–24.CrossRefPubMed
2.
go back to reference Vazirani J, Wurity S, Ali MH. Multidrug-resistant pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes. Ophthalmology. 2015;122(10):2110–4.CrossRefPubMed Vazirani J, Wurity S, Ali MH. Multidrug-resistant pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes. Ophthalmology. 2015;122(10):2110–4.CrossRefPubMed
3.
go back to reference Oldenburg CE, et al. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol. 2013;20(3):155–8.CrossRefPubMedPubMedCentral Oldenburg CE, et al. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol. 2013;20(3):155–8.CrossRefPubMedPubMedCentral
4.
go back to reference Paul-Satyaseela M, et al. Characterization of antibiotic resistance profiles of ocular enterobacteriaceae isolates. Eur J Microbiol Immunol (Bp). 2016;6(1):40–8.CrossRef Paul-Satyaseela M, et al. Characterization of antibiotic resistance profiles of ocular enterobacteriaceae isolates. Eur J Microbiol Immunol (Bp). 2016;6(1):40–8.CrossRef
5.
go back to reference Magiorakos AP, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infection. 2012;18(3):268–81. Magiorakos AP, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infection. 2012;18(3):268–81.
6.
go back to reference Fernandes M, et al. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefes Arch Clin Exp Ophthalmol. 2016;254(2):315–22.CrossRefPubMed Fernandes M, et al. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefes Arch Clin Exp Ophthalmol. 2016;254(2):315–22.CrossRefPubMed
7.
go back to reference Muluye D, et al. Types and drug susceptibility patterns of bacterial isolates from eye discharge samples at Gondar university hospital, northwest Ethiopia. BMC Res Notes. 2014;7:292.CrossRefPubMedPubMedCentral Muluye D, et al. Types and drug susceptibility patterns of bacterial isolates from eye discharge samples at Gondar university hospital, northwest Ethiopia. BMC Res Notes. 2014;7:292.CrossRefPubMedPubMedCentral
8.
go back to reference Haas W, et al. Monitoring antibiotic resistance in ocular microorganisms: results from the antibiotic resistance monitoring in ocular micRorganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol. 2011;152(4):567–74. e3.CrossRefPubMed Haas W, et al. Monitoring antibiotic resistance in ocular microorganisms: results from the antibiotic resistance monitoring in ocular micRorganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol. 2011;152(4):567–74. e3.CrossRefPubMed
9.
go back to reference Asbell PA, et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 2008;145(6):951–8.CrossRefPubMed Asbell PA, et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 2008;145(6):951–8.CrossRefPubMed
10.
go back to reference Thornsberry C, et al. Regional trends in antimicrobial resistance among clinical isolates of streptococcus pneumoniae, haemophilus influenzae, and moraxella catarrhalis in the united states: results from the TRUST surveillance program, 1999–2000. Clin Infect Dis. 2002;34 Suppl 1:S4–S16.CrossRefPubMed Thornsberry C, et al. Regional trends in antimicrobial resistance among clinical isolates of streptococcus pneumoniae, haemophilus influenzae, and moraxella catarrhalis in the united states: results from the TRUST surveillance program, 1999–2000. Clin Infect Dis. 2002;34 Suppl 1:S4–S16.CrossRefPubMed
11.
go back to reference Karlowsky JA, et al. Susceptibility to fluoroquinolones among commonly isolated gram-negative bacilli in 2000: TRUST and TSN data for the united states. Tracking resistance in the united states today. The surveillance network. Int J Antimicrob Agents. 2002;19(1):21–31.CrossRefPubMed Karlowsky JA, et al. Susceptibility to fluoroquinolones among commonly isolated gram-negative bacilli in 2000: TRUST and TSN data for the united states. Tracking resistance in the united states today. The surveillance network. Int J Antimicrob Agents. 2002;19(1):21–31.CrossRefPubMed
12.
go back to reference Sahm DF, et al. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST surveillance initiative, 2001–2005. Postgrad Med. 2008;120(3 Suppl 1):8–15.CrossRefPubMed Sahm DF, et al. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST surveillance initiative, 2001–2005. Postgrad Med. 2008;120(3 Suppl 1):8–15.CrossRefPubMed
13.
go back to reference Asbell PA, et al. Antibiotic resistance among ocular pathogens in the united states: five-year results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study. JAMA Ophthalmol. 2015;133(12):1445–54.CrossRefPubMed Asbell PA, et al. Antibiotic resistance among ocular pathogens in the united states: five-year results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study. JAMA Ophthalmol. 2015;133(12):1445–54.CrossRefPubMed
14.
go back to reference McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg. 2010;36(9):1588–498.CrossRefPubMed McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg. 2010;36(9):1588–498.CrossRefPubMed
15.
go back to reference Gentile RC, et al. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-years review. Ophthalmology. 2014;121(8):1634–42.CrossRefPubMed Gentile RC, et al. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-years review. Ophthalmology. 2014;121(8):1634–42.CrossRefPubMed
16.
go back to reference Blanco AR, et al. Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy. Curr Eye Res. 2013;38(8):811–6.CrossRefPubMed Blanco AR, et al. Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy. Curr Eye Res. 2013;38(8):811–6.CrossRefPubMed
17.
go back to reference Willcox MD. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom. 2011;94(2):161–8.CrossRefPubMed Willcox MD. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom. 2011;94(2):161–8.CrossRefPubMed
19.
go back to reference Al-Dhaheri HS, et al. Ocular pathogens and antibiotic sensitivity in bacterial keratitis isolates at king khaled Eye specialist hospital, 2011 to 2014. Cornea. 2016;35(6):789–94.CrossRefPubMed Al-Dhaheri HS, et al. Ocular pathogens and antibiotic sensitivity in bacterial keratitis isolates at king khaled Eye specialist hospital, 2011 to 2014. Cornea. 2016;35(6):789–94.CrossRefPubMed
20.
go back to reference Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing, in M100. 2010–2016. Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing, in M100. 2010–2016.
21.
go back to reference Clinical Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated fastidious bacteria, M45 S2. 2nd ed. 2011. Clinical Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated fastidious bacteria, M45 S2. 2nd ed. 2011.
22.
go back to reference Mantadakis E, et al. Antimicrobial susceptibility of Gram-positive cocci isolated from patients with conjunctivitis and keratitis in Crete, Greece. J Microbiol Immunol Infect. 2013;46(1):41–7.CrossRefPubMed Mantadakis E, et al. Antimicrobial susceptibility of Gram-positive cocci isolated from patients with conjunctivitis and keratitis in Crete, Greece. J Microbiol Immunol Infect. 2013;46(1):41–7.CrossRefPubMed
23.
go back to reference Asbell PA, et al. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg. 2008;34(5):814–8.CrossRefPubMed Asbell PA, et al. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg. 2008;34(5):814–8.CrossRefPubMed
24.
go back to reference Adebayo A, et al. Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary. Graefes Arch Clin Exp Ophthalmol. 2011;249(1):111–9.CrossRefPubMed Adebayo A, et al. Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary. Graefes Arch Clin Exp Ophthalmol. 2011;249(1):111–9.CrossRefPubMed
25.
go back to reference Kale SS, Namita A, Sachin Y. The epidemiology of aging, Aging, infection, and immunity. Netherlands: Springer; 2012. Kale SS, Namita A, Sachin Y. The epidemiology of aging, Aging, infection, and immunity. Netherlands: Springer; 2012.
26.
go back to reference Chuang CC, et al. Staphylococcus aureus ocular infection: methicillin-resistance, clinical features, and antibiotic susceptibilities. PLoS One. 2012;8(8):e42437.CrossRefPubMed Chuang CC, et al. Staphylococcus aureus ocular infection: methicillin-resistance, clinical features, and antibiotic susceptibilities. PLoS One. 2012;8(8):e42437.CrossRefPubMed
27.
go back to reference Rolain JM, et al. Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something? Clin Microbiol Infect. 2015;21(6):515–7.CrossRefPubMed Rolain JM, et al. Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something? Clin Microbiol Infect. 2015;21(6):515–7.CrossRefPubMed
28.
go back to reference Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta: CDC; 2013. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta: CDC; 2013.
29.
go back to reference Bertino Jr JS. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol. 2009;3:507–21.CrossRefPubMedPubMedCentral Bertino Jr JS. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol. 2009;3:507–21.CrossRefPubMedPubMedCentral
30.
go back to reference Sharma S. Antibiotic resistance in ocular bacterial pathogens. Indian J Med Microbiol. 2011;29(3):218–22.CrossRefPubMed Sharma S. Antibiotic resistance in ocular bacterial pathogens. Indian J Med Microbiol. 2011;29(3):218–22.CrossRefPubMed
31.
go back to reference Parmar P, et al. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. Am J Ophthalmol. 2006;141(2):282–6.CrossRefPubMed Parmar P, et al. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. Am J Ophthalmol. 2006;141(2):282–6.CrossRefPubMed
32.
go back to reference Kaliamurthy J, et al. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics. Ophthalmic Res. 2005;37(3):117–22.CrossRefPubMed Kaliamurthy J, et al. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics. Ophthalmic Res. 2005;37(3):117–22.CrossRefPubMed
33.
go back to reference Ray KJ, et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmol. 2013;131(3):310–3.CrossRefPubMed Ray KJ, et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmol. 2013;131(3):310–3.CrossRefPubMed
34.
go back to reference Rameshkumar G, et al. Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections. Indian J Ophthalmol. 2016;64(4):303–11.CrossRefPubMedPubMedCentral Rameshkumar G, et al. Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections. Indian J Ophthalmol. 2016;64(4):303–11.CrossRefPubMedPubMedCentral
Metadata
Title
Retrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at Mount Sinai Hospital, 2010 to 2015
Authors
Marko Oydanich
Tanis C. Dingle
Camille L. Hamula
Claudia Ghisa
Penny Asbell
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2017
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-017-0185-0

Other articles of this Issue 1/2017

Antimicrobial Resistance & Infection Control 1/2017 Go to the issue